Tenet Healthcare's shares closed up 1.8% following Q1 2026 results, reflecting a neutral to mildly positive investor response as the company delivered results above its own expectations and reaffirmed full-year guidance. Investors appeared comfortable with steady hospital margins, solid ASC growth, and ongoing productivity measures, despite ongoing payer mix headwinds and unchanged guidance.
Tenet Healthcare reported robust Q3 2025 results, with net operating revenues reaching $5.3 billion and adjusted EBITDA climbing 12% year-over-year to $1.1 billion, driven by strong same-store growth and operational efficiencies.